Dynavax to Present at the William Blair & Co. Annual Growth Stock Conference
June 03 2019 - 4:05PM
Dynavax Technologies Corporation (NASDAQ: DVAX), today announced
that Ryan Spencer, Senior Vice President, Commercial, and Interim
Co-President, will present at the William Blair & Co. Annual
Growth Stock Conference on Thursday, June 6, at 9:20 a.m.
C.T.
The presentation will be webcast and may be
accessed at the “Events & Presentations” section of the
Company’s website at
http://investors.dynavax.com/events-presentations.
About DynavaxDynavax is a
fully-integrated biopharmaceutical company focused on leveraging
the power of the body's innate and adaptive immune responses
through toll-like receptor (TLR) stimulation. Dynavax discovers and
develops novel vaccines and immuno-oncology therapeutics. The
Company is currently exploring strategic alternatives for its
immuno-oncology portfolio. The Company launched its first
commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant),
Adjuvanted], in February 2018, following U.S. FDA approval for
prevention of infection caused by all known subtypes of hepatitis B
virus in adults age 18 years and older. For more information, visit
www.dynavax.com.
Contact:
Heather Rowe
Vice President, Investor Relations & Corporate Communications
hrowe@dynavax.com
510-665-7269
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Sep 2023 to Sep 2024